ALTG vs FLX

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and profitability deterioration. Despite a bullish analyst recommendation and a high dividend yield, the company is deeply unprofitable (ROE: -160.65%, Profit Margin: -4.34%), leveraged excessively (Debt/Equity: 420.97), and has consistently missed earnings estimates by wide margins. Revenue is declining, cash flow metrics are unavailable, and the Price/Book ratio of 71.44 suggests extreme overvaluation relative to book value. While the stock has rallied 36.8% in the last month, long-term performance remains deeply negative with a 5Y change of -32.2%, raising concerns of speculative momentum rather than fundamental recovery.

FLX exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and negligible debt (D/E 0.03), suggesting a stable balance sheet. However, this financial stability is contrasted by a severe lack of growth, with Q/Q revenue declining by 12.93% and a disastrous 5-year price performance of -86.8%. While the stock trades below its Graham Number ($2.90), indicating a defensive value, the bearish technical trend (0/100) and shrinking top line suggest a potential value trap. The company is fundamentally healthy but operationally stagnant.